Kaiyin Yang | Molecular Biology | Research Excellence Award

Published on by Analytical Chemistry

Dr. Kaiyin Yang | Molecular Biology | Research Excellence Award

North China University of Science and Technology | China

Dr. Kaiyin Yang is a pharmacologist with a Doctor of Medicine degree, specializing in protein structure-based drug discovery and small-molecule targeted protein degradation. His research focuses on the rational design, synthesis, and mechanistic evaluation of novel anticancer agents, particularly PROTACs and enzyme-targeting small molecules. As Principal Investigator of a Hebei Provincial Youth Science Fund project, he is developing innovative HK2-targeting degraders for colon cancer therapy. His work also includes kinase inhibitors, metabolic enzyme modulation, and natural product-derived anticancer compounds. Dr. Yang’s studies integrate medicinal chemistry, chemical biology, and pharmacological approaches to advance precision oncology and targeted cancer therapeutics.

Citation Metrics (Scopus)

600
 400
 200
  50
     0

Citations
554

Documents
13

h-index
11

Citations

Documents

h-index

View Scopus Profile

Featured Publications

Vijaya Sarangthem | Biochemistry | Best Researcher Award

Published on by Analytical Chemistry

Dr. Vijaya Sarangthem | Biochemistry | Best Researcher Award

Research Professor | Kyungpook National University | South Korea

Dr. Sarangthem Vijaya Devi is an innovative biomedical scientist with over twelve years of expertise in biopolymer-based drug delivery, regenerative medicine, and nanotechnology, focusing on the design and development of elastin-like polypeptide (ELP)–based biomaterials for targeted therapeutics. Her doctoral research at Kyungpook National University, South Korea, involved constructing IL-4 receptor–targeting ELP systems for precise drug delivery, laying the foundation for her pioneering work in tumor-targeted cancer therapy and gene delivery. As a postdoctoral fellow, she led the development of multivalent ELP nanoparticles and depot systems, optimizing pharmacokinetics and tissue biodistribution, and establishing platforms for enhanced therapeutic efficacy. At AIIMS, New Delhi, Dr. Vijaya Devi advanced regenerative medicine applications by developing self-assembling ELP hydrogels and 3D scaffolds for mesenchymal stem cell culture, differentiation, and tissue regeneration. She further integrated 3D bioprinting technologies to create artificial tissue models for high-throughput drug screening and preclinical evaluation. Her ongoing work as a visiting research professor at Kyungpook National University focuses on ELP-driven 3D culture platforms, enabling scalable and reproducible organoid and spheroid models for precision medicine. Dr. Vijaya Devi’s research portfolio includes over 16 high-impact publications, several as corresponding or first author, highlighting her contributions to nanoparticle engineering, biomaterial optimization, and translational therapeutics. She has contributed to patents on ELP-based hydrogels for tissue regeneration and nanocarriers for oncology drug delivery, demonstrating the translational potential of her work. Recognized with multiple awards, including the Best Article Award and DST Fellowship, her research bridges fundamental science with industry applications, emphasizing scalability, regulatory compliance, and interdisciplinary collaboration. Her expertise encompasses gene delivery systems, molecular imaging, biomaterials engineering, and organoid culture, making her a leading researcher in precision therapeutics. Dr. Vijaya Devi continues to drive innovations in ELP biomaterials for cancer therapy, tissue engineering, and high-throughput drug discovery, positioning her as a global leader in biomedical research and translational medicine.

Profiles : Scopus | ORCID | Google Scholar | Research Gate

Featured Publications

  • Lee, Y.-J., Hong, J., Seo, B.-Y., Lee, B.-H., Sarangthem, V.*, & Park, R.-W. (2025). Strategic optimization of nanoparticle characteristics to enhance tumor targeting and doxorubicin delivery. International Journal of Nanomedicine, 20, 6357–6378.

  • Hong, J., Sim, D., Lee, B.-H., Sarangthem, V.*, & Park, R.-W. (2024). Multifunctional elastin-like polypeptide nanocarriers for efficient miRNA delivery in cancer therapy. Journal of Nanobiotechnology, 22(1), 293.

  • Sarangthem, V., Sharma, H., Mendiratta, M., Sahoo, R. K., Park, R.-W., Kumar, L., Singh, T. D., & Mohanty, S. (2022). Application of bio-active elastin-like polypeptide on regulation of human mesenchymal stem cell behavior. Biomedicines, 10(5), 1151.

  • Sarangthem, V.*, Sharma, H., Goel, R., Ghose, S., Park, R.-W., Mohanty, S., Chaudhuri, T. K., Dinda, A. K., & Singh, T. D. (2022). Application of elastin-like polypeptide (ELP) containing extracellular matrix (ECM) binding ligands in regenerative medicine. International Journal of Biological Macromolecules.

  • Sarangthem, V., Yi, A., Kim, Y., Rehemtulla, A., Lee, B.-H., Jeon, Y. H., Singh, T. D., & Park, R.-W. (2021). Therapeutic effect of IL4 receptor targeting pro-apoptotic peptide (AP1-ELP-KLAK) in glioblastoma tumor model. International Journal of Nanomedicine, 16, 5039–5052.

 

Ghanshyam Teli | Medicinal Chemistry | Best Researcher Award

Published on by Analytical Chemistry

Mr. Ghanshyam Teli | Medicinal Chemistry | Best Researcher Award

School of Pharmacy, Sangam University, India

👨‍🎓Profiles

👨‍🎓 Early Academic Pursuits

Mr. Ghanshyam Teli’s academic journey began with a strong foundation in pharmacy. He earned his B. Pharmacy from Geetanjali University in 2019 with a commendable 73.7%. His academic pursuit continued with a M. Pharmacy from ISF College of Pharmacy in 2021, where he achieved an impressive 82%. Currently, he is pursuing his Ph.D. at Baba Farid University of Health Sciences, enhancing his expertise in the field. His early academic focus was on chemical synthesis and drug discovery, where he worked on several research projects related to anti-cancer agents and inhibitors of oncogenic pathways.

🧑‍🔬 Professional Endeavors

Mr. Teli has gained considerable professional experience, particularly in both academic and industrial settings. He has worked for 1.5 years as an Assistant Professor at the School of Pharmacy, Sangam University, Bhilwara, India, where he has been able to share his knowledge with students while continuing his research. His professional experience also includes 13 months at United Biotech Pvt Ltd as an Assistant R&D Chemist, where he contributed to several high-impact projects, including the synthesis of 4-Thiazolidinone derivatives and the development of Paclitaxel-HSA complex. Additionally, he spent 1 year as a Junior Research Fellow (JRF) at Acharya and B.M. Reddy College of Pharmacy in Bengaluru, further strengthening his research expertise.

🔬 Contributions and Research Focus

Mr. Teli's research contributions have primarily focused on drug design, synthesis, and evaluation, with a particular emphasis on creating compounds for anti-cancer treatment. His work on 4-thiazolidinone conjugates as potential anti-breast cancer agents is notable, along with his project on the discovery of triangular heterocyclic molecules to inhibit dual oncogenic pathways. His research aims to contribute to developing novel therapeutic strategies for cancer treatment, especially targeting HSP90 and BRAF kinases.

🌍 Impact and Influence

Mr. Teli's professional journey demonstrates his commitment to both academia and industry. His industrial experience has allowed him to engage in multi-step synthesis processes and biological evaluations, making a tangible impact on pharmaceutical development. As an educator, he strives to impart his knowledge and inspire the next generation of pharmacists, sharing insights from both his research and industry experience. His contributions aim to foster innovations in drug design and therapy, particularly in cancer treatments.

📚 Academic Cites and Recognition

While Mr. Teli’s academic work is still evolving, his research projects on drug discovery, particularly in the field of cancer, have the potential for future recognition and citations. His detailed work in the design and synthesis of bioactive compounds, particularly those related to anti-cancer and anti-breast cancer agents, is likely to gain traction and be cited by peers in the academic and research communities.

💻 Technical Skills

Mr. Teli is proficient in several technical aspects of pharmaceutical chemistry, including: Synthesis of chemical compounds and characterization through advanced spectroscopy techniques such as UV, IR, and 1H NMR. Docking studies and predicting ADMET properties (Absorption, Distribution, Metabolism, Excretion, and Toxicity) for potential drug candidates. Handling specialized equipment such as Flash Chromatography, Column Chromatography, Rota-evaporator, Vacuum dryer, UV-Vis Spectrophotometer, and pH meter. Expertise in computational tools like ChemDraw, Autodock, Molegro Virtual Docker (MVD), Pymol, and Discovery Studio, which aid in the structure-activity relationship (SAR) analysis and molecular modeling.

👩‍🏫 Teaching Experience

As an Assistant Professor at the School of Pharmacy, Sangam University, Mr. Teli has honed his teaching skills, fostering a rich learning environment. His ability to explain complex concepts in pharmacy and drug design to students reflects his deep knowledge and communication skills. His teaching approach emphasizes practical application and encourages critical thinking. By sharing his industrial and research experiences, he connects students with real-world pharmaceutical challenges, aiming to inspire future innovations.

🌱 Legacy and Future Contributions

Mr. Teli’s ongoing research and academic efforts hold significant promise for the future of pharmacy education and drug discovery. His work on the synthesis of novel anti-cancer agents, especially those targeting key oncogenic pathways, has the potential to drive breakthroughs in cancer therapy. As he continues to pursue his Ph.D., Mr. Teli is committed to growing as a researcher and educator. He seeks to expand his knowledge, hone his technical skills, and make valuable contributions to drug development while guiding the next generation of pharmaceutical professionals.

📖Notable Publications

  • Synthetic product-based approach toward potential antileishmanial drug development
  • Authors: Pal, R., Teli, G., Akhtar, M.J., Matada, G.S.P.
    Journal: European Journal of Medicinal Chemistry
    Year: 2024
  • An outlook of docking analysis and structure-activity relationship of pyrimidine-based analogues as EGFR inhibitors against non-small cell lung cancer (NSCLC)
  • Authors: Pal, R., Teli, G., Sengupta, S., Maji, L., Purawarga Matada, G.S.
    Journal: Journal of Biomolecular Structure and Dynamics
    Year: 2024
  • Explanatory review on pyrimidine/fused pyrimidine derivatives as anticancer agents targeting Src kinase
  • Authors: Teli, G., Pal, R., Maji, L., Purawarga Matada, G.S., Sengupta, S.
    Journal: Journal of Biomolecular Structure and Dynamics
    Year: 2024
  • Designing strategies, structural activity relationship and biological activity of recently developed nitrogen containing heterocyclic compounds as epidermal growth factor receptor tyrosinase inhibitors
  • Authors: Pal, R., Teli, G., Matada, G.S.P., Dhiwar, P.S.
    Journal: Journal of Molecular Structure
    Year: 2023
  • The role of natural anti-parasitic guided development of synthetic drugs for leishmaniasis
  • Authors: Pal, R., Teli, G., Akhtar, M.J., Matada, G.S.P.
    Journal: European Journal of Medicinal Chemistry
    Year: 2023

 

 

Khairy Mohamed Abdalla Zoheir | Medicinal Chemistry | Best Researcher Award

Published on by Analytical Chemistry

Prof. Dr. Khairy Mohamed Abdalla Zoheir | Medicinal Chemistry | Best Researcher Award

National Research Centre, Egypt

👨‍🎓Profiles

🎓 Early Academic Pursuits

Dr. Khairy Mohamed Abdalla Zoheir began his distinguished academic journey with a focus on genetics, cytology, and histology. He earned both his Ph.D. and MD from Cairo University, Egypt, in July 2005. His early research laid the foundation for his future work in animal genetics and molecular biology. In pursuit of advanced knowledge, Dr. Zoheir received a two-year postdoctoral fellowship at the College of Science and Technology, Huazhong Agricultural University, Wuhan, China (2006–2008), where he deepened his expertise in cutting-edge genetic research.

💼 Professional Endeavors

Dr. Zoheir has built an illustrious career as a Professor of Animal Genetics at the Cell Biology Department, Biotechnology Research Institute, National Research Centre, Cairo, Egypt. His international experience includes a tenure as Assistant Professor of Pharmacology and Toxicology at the College of Pharmacy, King Saud University, Riyadh, Saudi Arabia, from 2009 onward. Through these roles, he has contributed significantly to advancing the understanding of gene therapy and pharmacology, cementing his place as a leader in his field.

🧬 Contributions and Research Focus

Dr. Zoheir’s research revolves around RNA interference (RNAi), overexpression studies, epigenetics, and gene therapy for diseases such as cancer. His groundbreaking work extends to novel therapeutic approaches, including the development of an internationally patented anti-inflammatory topical gel containing myrrh extract (2016). His research findings also highlight the role of lipoic acid in modulating cytokines, thereby influencing wound healing. With 92 publications in SCI and Scopus-indexed journals, his contributions have significantly impacted the fields of molecular biology and pharmacology.

🌟 Impact and Influence

Dr. Zoheir’s work has garnered widespread recognition in both national and international scientific communities. His research funding achievements and numerous conference presentations underscore his commitment to knowledge dissemination and collaboration. He has authored 85 publications in prestigious journals, influencing emerging fields such as epigenetics and gene therapy. Additionally, his editorial appointment with Frontiers in Molecular Biosciences showcases his leadership in shaping the future of molecular biology research.

📚 Academic Cites and Publications

With a total of 92 SCI-indexed and Scopus-indexed publications, Dr. Zoheir has made a lasting impact on the scientific world. His work continues to be cited by peers worldwide, further establishing his reputation as a prolific researcher in molecular genetics, RNAi, and gene therapy.

🛠️ Technical Skills

Dr. Zoheir is adept in advanced molecular biology techniques such as RNA interference, gene overexpression, and epigenetics. His expertise also includes pharmacological studies and the development of novel therapeutic formulations, exemplified by his internationally patented myrrh-based topical gel.

🧑‍🏫 Teaching Experience

Throughout his career, Dr. Zoheir has demonstrated a passion for education. He has mentored numerous students and researchers, fostering their growth in genetics and molecular biology. His teaching roles at the National Research Centre and King Saud University have helped train the next generation of scientists and researchers.

🌍 Legacy and Future Contributions

Dr. Zoheir’s legacy is marked by his innovative research, impactful publications, and commitment to advancing molecular biology. As a pioneer in RNAi and gene therapy, he continues to inspire researchers worldwide. His future contributions are expected to further unravel the complexities of epigenetics and therapeutic interventions, leaving an indelible mark on the scientific community.

📖Notable Publications